FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4521111000001109: Celance 50microgram tablets (Eli Lilly & Co Ltd) 109 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
26584701000001114 Celance 50microgram tablets (Eli Lilly & Co Ltd) 109 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
41474601000001116 Celance 50microgram tablets (Eli Lilly and Company Ltd) 109 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Celance 50microgram tablets (Eli Lilly & Co Ltd) 109 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Celance 50microgram tablets (Eli Lilly & Co Ltd) 109 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Celance 50microgram tablets (Eli Lilly & Co Ltd) 109 tablet Is a Pergolide 50microgram tablets 109 tablet true Inferred relationship Existential restriction modifier
Celance 50microgram tablets (Eli Lilly & Co Ltd) 109 tablet Is pack of Celance 50microgram tablets (Eli Lilly & Co Ltd) false Inferred relationship Existential restriction modifier
Celance 50microgram tablets (Eli Lilly & Co Ltd) 109 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Celance 50microgram tablets (Eli Lilly & Co Ltd) 109 tablet Has active ingredient Pergolide mesilate false Inferred relationship Existential restriction modifier
Celance 50microgram tablets (Eli Lilly & Co Ltd) 109 tablet Has active ingredient Pergolide false Inferred relationship Existential restriction modifier
Celance 50microgram tablets (Eli Lilly & Co Ltd) 109 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Celance 50microgram tablets (Eli Lilly & Co Ltd) 109 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Celance 50microgram tablets (Eli Lilly & Co Ltd) 109 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Celance 50microgram tablets (Eli Lilly & Co Ltd) 109 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Celance 50microgram tablets (Eli Lilly & Co Ltd) 109 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Celance 50microgram tablets (Eli Lilly & Co Ltd) 109 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Celance 50microgram tablets (Eli Lilly & Co Ltd) 109 tablet Has AMP Celance 50microgram tablets (Eli Lilly & Co Ltd) true Inferred relationship Existential restriction modifier
Celance 50microgram tablets (Eli Lilly & Co Ltd) 109 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Pergolide true Inferred relationship Existential restriction modifier
Celance 50microgram tablets (Eli Lilly & Co Ltd) 109 tablet Has specific active ingredient Pergolide mesilate true Inferred relationship Existential restriction modifier
Celance 50microgram tablets (Eli Lilly & Co Ltd) 109 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Celance 50microgram tablets (Eli Lilly & Co Ltd) 109 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Celance 50microgram tablets (Eli Lilly & Co Ltd) 109 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Celance 50microgram tablets (Eli Lilly & Co Ltd) 109 tablet Has basis of strength substance Pergolide true Inferred relationship Existential restriction modifier
Celance 50microgram tablets (Eli Lilly & Co Ltd) 109 tablet VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Celance 50microgram tablets (Eli Lilly & Co Ltd) 109 tablet VMP non-availability indicator Re-introduced false Inferred relationship Existential restriction modifier
Celance 50microgram tablets (Eli Lilly & Co Ltd) 109 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start